The Global Bio-Implants market accounted for a market size of USD billion in 2015 and is estimated to reach USD 108 billion in 2020, growing at a CAGR of 8.1 % during the forecast period. Bio-implants are medical devices that replace a missing biological structure or augment the functioning of an existing biological structure. There are three types of bio-implants viz. biological implants, bio-logised implants and bio-functionalised implants. These implants can be manufactured from living cells using tissue engineering techniques. They consist of cells produced naturally in the body so that the risk of rejection is minimized and the self-healing ability is enhanced.
Rise in the incidence of chronic diseases, increase in per capita income, rise in the number of aging population, increase in public and private investments, rising awareness about bio-implants and research dedicated towards compact bio-implants are some of the factors augmenting the growth of the market. However, biocompatibility issues and high cost of implants are some of the reasons hindering the market growth.
The Global Bio-Implants Market is segregated on the basis of Type of Implants, materials, and origin. The Segmentation based of type consists of Dental Implants (includes Plate form dental implants and Root form dental implants), Cardiovascular Implants (includes Stents, Pacing Devices,and structural cardiac implants), Spinal Implants (includes Thoracolumber implants, Intervertebral spacers, Motion Preservation implants and Implantable spinal stimulators), Orthopedic Implants (includes Orthobiologics, Trauma implants, Joint Replacement implants and Knee Replacement implants], Ophthalmic Implants (includes Glaucoma Implants and Intraocular Lens), Neurostimulator Implants (includes Sacral nerve stimulators, Vagus nerve stimulators, Deep brain stimulators) and Other Implants. The segmentation based on Material have been sub-divided into Metals & Alloys, Ceramics and Polymers. The segmentation based on Origin have been sub-divided into Xenograft, Synthetic, Allograft and Autograft.
The global Bio-Implants market have been geographically segmented into North America, Europe, Asia-Pacific, Middle East and North Africa, and South America. The segmentation on North America includes USA, Canada and Mexico. The Europe segment have been subdivided into UK, France, Italy, Germany, Benelux, Scandinavia, Spain and rest of Europe. The segmentation on Asia-Pacific have been subdivided into China, Japan, India, South Korea, Australia, and New Zealand. The Middle-east & North Africa segment includes GCC, Egypt, and others. The South America region includes Brazil, Argentina, and others.
North America has the largest market share, followed by Europe and Asia-Pacific. However, Asia-Pacific market is expected to grow at the highest CAGR. The Key players in this market are Medtronic, Inc., Stryker Corporation, Boston Scientific Corporation, Smith and Nephew, Abbott Laboratories, Bausch and Lomb, Biomet Inc., DePuy Synthes, Wright Medical group and St. Jude Medical, Inc.
By tegrafik from Pixabay